GZMB and neoplasm: Next, using KIL cells as a murine model of an NK cell therapeutic, we mechanistically demonstrated that an inhibitor of WEE1 kinase, AZD1775, can be used to reverse tumor cell G2/M cell cycle checkpoint activation (leading to a G2/M block) following exposure to NK cell granzyme B, leading to increased tumor cell DNA damage and cell death.